WhyOSA
AI-powered platform that matches sleep apnea patients to the right treatment.
Company Overview
Snapshot
Founded in March 2026 by Ran Manevich and Shahar Levi, WhyOSA operates with 1–10 employees. The company has secured funding across one round from one investor, ICI Fund, to advance its AI-powered clinical decision-support platform for obstructive sleep apnea.
Business overview
WhyOSA develops a clinical decision-support platform for obstructive sleep apnea (OSA). The company's core technology combines patient data, clinical evidence, and AI models to assist physicians in identifying the most suitable treatment for each patient, aiming to reduce trial-and-error in therapy selection. The platform serves sleep medicine providers and healthcare organizations, operating within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices.
Log in to access full profile ›Company Intelligence Q&A
- When was WhyOSA founded?
- WhyOSA was founded in March 2026 by Ran Manevich and Shahar Levi.
- What is WhyOSA's primary focus?
- WhyOSA focuses on developing an AI-powered clinical decision-support platform for obstructive sleep apnea (OSA), aiming to personalize treatment selection and improve patient outcomes.
- Which sector does WhyOSA operate in?
- WhyOSA operates within the Health Tech & Life Sciences sector, with a specific focus on Medical Devices.
- What is the current employee count for WhyOSA?
- WhyOSA currently has 1–10 employees.
- Has WhyOSA received any funding?
- WhyOSA secured Seed funding in March 2026 from ICI Fund.